Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,518 public trials 2,834 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

NCT03961009

Conditions
Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Dr. Henry J. Kanarek - Allergy, Asthma & Immunology Overland Park, Kansas, United States
  • Midwest Immunology Clinic and Infusion Center Plymouth, Minnesota, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy, Drug Levels and Safety of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in Chinese and Japanese Participants With Ring Sideroblasts Who Require Red Blood Cell Transfusions

NCT04477850

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations
  • Local Institution - 100 Beijing, China
  • Local Institution - 107 Chengdu, Sichuan, China
  • Local Institution - 105 Guangzhou, China
  • Local Institution - 103 Guangzhou, China
View all 25 locations
View Trial Details
Completed

Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma

NCT05064358

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • GSK Investigational Site West Palm Beach, Florida, United States
  • GSK Investigational Site Kansas City, Missouri, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Chattanooga, Tennessee, United States
View all 77 locations
View Trial Details
Completed

Phase III Study on HMPL-523 for Treatment of ITP

NCT05029635

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The First Affiliated hospital of USTC Hefei, Anhui, China
  • Beijing Chaoyang Hospital of Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 37 locations
View Trial Details

Related conditions